HeartBeam, Inc. (BEAT) vs Elicio Therapeutics, Inc. (ELTX)

A side-by-side comparison of HeartBeam, Inc. and Elicio Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
HeartBeam, Inc. logo
BEAT
HeartBeam, Inc.
$33M
$0.60HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
Elicio Therapeutics, Inc. logo
ELTX
Elicio Therapeutics, Inc.
$36M
$1.91HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT

Total return — BEAT vs ELTX

growth of $100 · dividends reinvested · last 3y
BEAT -47.2% (-19.2%/yr)ELTX -67.4% (-31.2%/yr)BEAT compounded faster over this window
50100150200250Start $100202420252026$53$33
BEAT ELTX

BEAT vs ELTX: by the numbers

  • •ELTX is the larger company ($36M vs $33M market cap).

Metrics side by side

Valuation

MetricBEATELTX
P/B ratio4.074.58

Profitability

MetricBEATELTX
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-248.21%-476.77%
ROIC-249.58%-171.36%

Go deeper

Full BEAT analysisFull ELTX analysisInteractive comparison tool

Dig into the metrics

HeartBeam ROEElicio Therapeutics ROEHeartBeam operating marginElicio Therapeutics operating marginHeartBeam revenue growthElicio Therapeutics revenue growthHeartBeam free cash flowElicio Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.